These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35266425)

  • 21. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution.
    Basha R; Connelly SF; Sankpal UT; Nagaraju GP; Patel H; Vishwanatha JK; Shelake S; Tabor-Simecka L; Shoji M; Simecka JW; El-Rayes B
    J Nutr Biochem; 2016 May; 31():77-87. PubMed ID: 27133426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Explore the mechanism of astragaloside IV-PESV on proliferation, migration, and autophagy of prostate cancer cells based on the PI3K/AKT signaling pathway].
    You XJ; Wen Z; Zheng QX; Li QX; Fu W; Li HS; Wang B
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):963-972. PubMed ID: 38639947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
    J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects of curcumin nanoemulsions on prostate cancer.
    Guan YB; Zhou SY; Zhang YQ; Wang JL; Tian YD; Jia YY; Sun YJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):371-378. PubMed ID: 28585133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment.
    Yallapu MM; Ebeling MC; Khan S; Sundram V; Chauhan N; Gupta BK; Puumala SE; Jaggi M; Chauhan SC
    Mol Cancer Ther; 2013 Aug; 12(8):1471-80. PubMed ID: 23704793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoemulsion based concomitant delivery of curcumin and etoposide: impact on cross talk between prostate cancer cells and osteoblast during metastasis.
    Shukla P; Mathur V; Kumar A; Khedgikar V; Teja VB; Chaudhary D; Kushwaha P; Bora HK; Konwar R; Trivedi R; Mishra PR
    J Biomed Nanotechnol; 2014 Nov; 10(11):3381-91. PubMed ID: 26000396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
    Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
    Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin Targets Both Apoptosis and Necroptosis in Acidity-Tolerant Prostate Carcinoma Cells.
    Lee YJ; Park KS; Lee SH
    Biomed Res Int; 2021; 2021():8859181. PubMed ID: 34095313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
    Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
    Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells.
    Tima S; Okonogi S; Ampasavate C; Berkland C; Anuchapreeda S
    Drug Dev Ind Pharm; 2019 Mar; 45(3):498-505. PubMed ID: 30572745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisdemethoxycurcumin Augments Docetaxel Efficacy for Treatment of Prostate Cancer.
    Song Y; Ruan J; Liu S; Yu H
    Biol Pharm Bull; 2024; 47(8):1437-1446. PubMed ID: 39143009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic Analysis of G2/M Arrest Triggered by Natural Borneol/Curcumin in HepG2 Cells, the Importance of the Reactive Oxygen Species-p53 Pathway.
    Chen J; Li L; Su J; Li B; Zhang X; Chen T
    J Agric Food Chem; 2015 Jul; 63(28):6440-9. PubMed ID: 26051007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation.
    Mohammed F; Rashid-Doubell F; Taha S; Cassidy S; Fredericks S
    Int J Oncol; 2020 Aug; 57(2):445-455. PubMed ID: 32626932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scorpion (
    Al-Asmari AK; Riyasdeen A; Abbasmanthiri R; Arshaduddin M; Al-Harthi FA
    Indian J Pharmacol; 2016; 48(5):537-543. PubMed ID: 27721540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin-Loaded TPGS/F127/P123 Mixed Polymeric Micelles for Cervical Cancer Therapy: Formulation, Characterization, and
    Wang J; Liu Q; Yang L; Xia X; Zhu R; Chen S; Wang M; Cheng L; Wu X; Wang S
    J Biomed Nanotechnol; 2017 Dec; 13(12):1631-1646. PubMed ID: 29490752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of curcumin loaded cellulose nanoparticles for prostate cancer.
    Yallapu MM; Dobberpuhl MR; Maher DM; Jaggi M; Chauhan SC
    Curr Drug Metab; 2012 Jan; 13(1):120-8. PubMed ID: 21892919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
    Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
    Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, Biological Evaluation and Action Mechanism Study of New Mitochondria-Targeted Curcumin Derivative as Potential Antitumor Drugs.
    Lu Z; Gao Z; Song H; Zhou Y; Yuan W; Wang X; Zhang L; Hong Y; Meng Y; Hu J; Zheng G; Chang C
    Chem Biodivers; 2023 Jul; 20(7):e202300086. PubMed ID: 37294554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.